What does MaxCyte, Inc. do?

MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein…

What is MaxCyte, Inc.'s P/E and P/B ratio?

MaxCyte, Inc. has a P/E ratio of -4.2 and a P/B ratio of 0.93.

What is MaxCyte, Inc.'s debt-to-equity ratio?

MaxCyte, Inc. has a debt-to-equity ratio of 0.11.

How much does MaxCyte, Inc. owe compared with what it owns?

MaxCyte, Inc. owes $0.14 for every $1 it owns (balance sheet Jun 2026), which is low.

Does MaxCyte, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?

Yes. MaxCyte, Inc. has 2 active red flags (PosiRed) on record: Stock exchange listing-rule deficiency notice (8-K Item 3.01) (dated 16 Jun 2026); Stock exchange listing-rule deficiency notice (8-K Item 3.01) (dated 20 Mar 2026). It has no yellow flags.

Where can I read the latest news about MaxCyte, Inc.?

Recent headlines about MaxCyte, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.

Does MaxCyte, Inc. have a PositoAI PosiShot or QR code?

Yes. A dated PosiShot of MaxCyte, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.

MaxCyte, Inc.

Q: What is MaxCyte, Inc.'s Positivity rank?

MaxCyte, Inc. is ranked #5,338 of 6,774 companies globally and #2,887 of 4,000 in United States on PositoAI, with a Positivity Score of 17,734.

NasdaqGS: MXCT · Healthcare

Positivity Index

#5,338 / 6,774

Global

#2,887 / 4,000

United States

Positivity Score

17,734

Rank→

PosiRed: 2 active red flags (highest severity 6/10) View flag history →

PosiRed · red flag

Stock exchange listing-rule deficiency notice (8-K Item 3.01)

The company reported in a Form 8-K (Item 3.01) filed on 16 Jun 2026 that its stock exchange notified it of not meeting a continued-listing rule. Continued non-compliance can lead to delisting.

More details →

PosiRed · red flag

Stock exchange listing-rule deficiency notice (8-K Item 3.01)

The company reported in a Form 8-K (Item 3.01) filed on 20 Mar 2026 that its stock exchange notified it of not meeting a continued-listing rule. Continued non-compliance can lead to delisting.

More details →

MaxCyte, Inc. — Overview & Financial Snapshot

MaxCyte, Inc. (NasdaqGS: MXCT) is a Healthcare company, ranked #5,338 of 6,774 companies globally and #2,887 of 4,000 in United States on PositoAI, with a Positivity Score of 17,734. Its market capitalisation is ₹1,393.07 Cr ($147.58M), P/E ratio is -4.2 and P/B ratio is 0.93. It currently has 2 active red flags (PosiRed) and no yellow flags (PosiYellow) on record.

For financial statements, ratio trends and score history, Go Deep →